Dec 3 (Reuters) - Johnson & Johnson unit Janssen Global Services said on Saturday that it does not intend to make an offer for biotech company Horizon Therapeutics Plc.
Last month, Horizon Therapeutics - which has a market capitalization of about $18 billion - said it was in talks with Amgen Inc, Sanofi and Janssen Global Services. (Reporting by Mrinmay Dey in Bengaluru, editing by Deepa Babington)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 273 USD | -0.19% | +3.39% | 146B | ||
| 87.7 EUR | -1.29% | +1.76% | 117B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +25.61% | 660B | |
| +25.87% | 562B | |
| -5.24% | 358B | |
| +16.49% | 322B | |
| +8.28% | 297B | |
| +7.09% | 219B | |
| -9.12% | 196B | |
| +5.01% | 199B | |
| -8.75% | 149B |
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY 
